Advertisement
Home Tags Cancer: Breast

Tag: Cancer: Breast

For patients undergoing breast reconstruction

Fat Grafting May Improve Outcome in Breast Reconstruction

Fat grafting linked to improvement satisfaction, psychosocial well-being, sexual well-being
For women aged 50 years or younger who have undergone breast conservation therapy

Adding MRI to Mammography Ups Detection of Breast Cancer

Findings in women aged ≤50 years who had undergone breast conservation therapy
Medicaid cuts could lead to an increase in the number of women diagnosed with late-stage breast cancer

More Breast Cancers Diagnosed at Late Stage With Medicaid Cuts

40.2 percent diagnosed late-stage after Medicaid cuts versus 35.4 percent before cuts
A community-based interventionist-guided weight-loss program is efficacious for early-stage African-American breast cancer survivors

Weight-Loss Program Aids Black Breast Cancer Survivors

Community-based, interventionist-guided weight loss program efficacious for early-stage survivors
Breast cancer risk peaks around the 40s for BRCA1 mutation carriers and around the 50s for BRCA2 carriers

Family Hx, Mutation Position Key Variables in BRCA1/2 Cancer Risk

Study findings provide cancer risk patterns based on BRCA status using prospective data
A nurse-led psychological intervention program is beneficial for patients with breast cancer at high risk of depression

Nurse-Led Psych Intervention Beneficial in Breast Cancer

Participants with high risk of depression reported lower mood disturbance, anxiety, depression
From 2013 to 2015 there was a decrease in additional surgery after initial lumpectomy

ASCO: Recent Drop in Additional Surgery Post Lumpectomy

Decrease was concomitant with 2014 consensus statement endorsing a margin of no ink on tumor
Olaparib (Lynparza) monotherapy can provide a significant benefit over standard therapy in women with human epidermal growth factor receptor type 2-negative metastatic breast cancer and a germline BRCA mutation

ASCO: Olaparib Efficacious in BRCA-Related Breast Cancer

May offer a new treatment for women with advanced BRCA-related disease, researchers say
Capecitabine (Xeloda) can extend the lives of patients with human epidermal growth factor receptor 2-negative breast cancer who have residual invasive disease after receipt of neoadjuvant chemotherapy

Certain Breast CA Patients Benefit From Adjuvant Capecitabine

Capecitabine cut risk of relapse, death by 30 percent over five years, researchers say
For patients with breast cancer receiving endocrine therapy

Daily Texting Effectively Monitors Rx Adherence, Side Effects

Most patients with breast cancer taking endocrine therapy report intervention helpful in taking drugs